Approval · Notice of Compliance 25607 · 2021
VISUDYNE: Notice of Compliance 25607
Issued April 6, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25607
- Date
- April 6, 2021
- Company
- Cheplapharm Arzneimittel GmbhGreifswald, Mecklenburg - West Pomerania, Germany
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Replacement of the Drug Product manufacturing site, change in primary packaging site, and downsizing of batch size
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VISUDYNE | Not yet assigned | — |
Medicinal ingredients
- VERTEPORFIN 15 MG per VIAL